-
patientregistry.ahrq.gov/news/newsletters/e-newsletter/861.html
April 01, 2023 - illicit substances in young children before and during the COVID-19 pandemic by substance type, including amphetamines
-
healthcare411.ahrq.gov/news/newsletters/e-newsletter/861.html
April 01, 2023 - illicit substances in young children before and during the COVID-19 pandemic by substance type, including amphetamines
-
teamstepps.ahrq.gov/news/newsletters/e-newsletter/861.html
April 01, 2023 - illicit substances in young children before and during the COVID-19 pandemic by substance type, including amphetamines
-
www.cahps.ahrq.gov/news/newsletters/e-newsletter/861.html
April 01, 2023 - illicit substances in young children before and during the COVID-19 pandemic by substance type, including amphetamines
-
www.monahrq.ahrq.gov/news/newsletters/e-newsletter/861.html
April 01, 2023 - illicit substances in young children before and during the COVID-19 pandemic by substance type, including amphetamines
-
www.cpsi.ahrq.gov/news/newsletters/e-newsletter/861.html
April 01, 2023 - illicit substances in young children before and during the COVID-19 pandemic by substance type, including amphetamines
-
www.healthcare411.ahrq.gov/news/newsletters/e-newsletter/861.html
April 01, 2023 - illicit substances in young children before and during the COVID-19 pandemic by substance type, including amphetamines
-
www.innovations.ahrq.gov/news/newsletters/e-newsletter/861.html
April 01, 2023 - illicit substances in young children before and during the COVID-19 pandemic by substance type, including amphetamines
-
www.talkingquality.ahrq.gov/news/newsletters/e-newsletter/861.html
April 01, 2023 - illicit substances in young children before and during the COVID-19 pandemic by substance type, including amphetamines
-
www.qualitymeasures.ahrq.gov/news/newsletters/e-newsletter/861.html
April 01, 2023 - illicit substances in young children before and during the COVID-19 pandemic by substance type, including amphetamines
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-update_research-protocol.pdf
August 18, 2016 - ADHD-Update-protocol-160818
Source: www.effectivehealthcare.ahrq.gov
Published online: August 18, 2016
Evidence-based Practice Center Systematic Review Protocol
Project Title: Attention Deficit Hyperactivity Disorder (ADHD)
Initial publication date if applicable: Nov 25, 2015
Amendment Date(s) if applicabl…
-
effectivehealthcare.ahrq.gov/products/disruptive-behavior-disorder/consumer
August 31, 2016 - Treating Disruptive Behavior Disorders in Children and Teens
Consumer Summary Archived August 31, 2016 Download Main Document PDF 3.6 MB
Archived: This report is greater than 3 years old. Findings may be used for research purposes, but should not be considered current.
Is This Information Right…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_consumer.pdf
August 01, 2016 - Treating Disruptive Behavior Disorders in Children and Teens
Treating Disruptive Behavior
Disorders in Children and Teens
A Review of the Research for Parents and Caregivers
e
Is This Information Right for Me?
This information is for you if:
� A health care professional* said your child or teen has a
disrupti…
-
hcup-us.ahrq.gov/reports/statbriefs/sb191-Hospitalization-Mental-Substance-Use-Disorders-2012.pdf
January 01, 2012 - http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp
9
ICD-9-CM diagnosis codes Description
Amphetamines … 304.40–304.43 Amphetamines dependence
305.70–305.73 Nondependent amphetamine abuse
Cannabis
-
effectivehealthcare.ahrq.gov/products/ptsd-repository-expanded/protocol
February 14, 2020 - exp Amphetamines/
(amphetamine or armodafanil or atomoxetine or dexmethylphenidate or dextroamphetamine
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-adults_research.pdf
November 01, 2011 - Regression models were not fit for amphetamines, atomoxetine, and pemoline, because there was only one … Current User 373,667 7 1.87 0.75 0.31-1.85
Methylphenidate 192,257 4 2.08 0.96 0.31-2.97
Amphetamines … ‡Because of low numbers of events for use of amphetamines, atomoxetine, and pemoline, regression models
-
effectivehealthcare.ahrq.gov/sites/default/files/adhd_disposition-comments.pdf
October 01, 2011 - Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers; Long-Term Effectiveness in All Ages; and Variability in Prevalence, Diagnosis, and Treatment
Source: http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-
reports/?pageaction=displayproduct&product…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorder_executive.pdf
October 01, 2015 - 1
Comparative Effectiveness Review
Number 154
Psychosocial and Pharmacologic Interventions
for Disruptive Behavior in Children and
Adolescents
Executive Summary
Background
Disruptive behavior disorders (DBDs) are
a group of related psychiatric disorders
of childhood and adolescence marked by
temper tantrums,…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/drug-use-illicit-primary-care-interventions-for-children-and-adolescents
August 30, 2018 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Final Research Plan
Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions
August 30, 2018
Recommendations made by the USPSTF are indepe…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-repository-expanded-protocol.pdf
October 24, 2019 - sertraline or trazadone or trimipramine or venlafaxine or vilazodone or vortioxetine).ti,ab.
24. exp Amphetamines